dmt310
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started May 22, 2018 (NCT03536637)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06090721 | Phase 3 | Dec 8, 2023 | Dermata Therapeutics |
| NCT04106778 | Phase 2 | Oct 30, 2019 | Dermata Therapeutics |
| NCT03536637 | Phase 2 | May 22, 2018 | Dermata Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dermata Therapeutics | For profit | 3 | 3 | 2 | 2018 |
1 organizations
Page 1 / 1